Kintara Therapeutics Stock Forecast - Daily Balance Of Power

KTRA Stock  USD 0.14  0.01  5.38%   
Kintara Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Kintara Therapeutics stock prices and determine the direction of Kintara Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Kintara Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns. Although Kintara Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Kintara Therapeutics' systematic risk associated with finding meaningful patterns of Kintara Therapeutics fundamentals over time.
Check out Historical Fundamental Analysis of Kintara Therapeutics to cross-verify your projections.
For information on how to trade Kintara Stock refer to our How to Trade Kintara Stock guide.
  
As of April 25, 2024, Inventory Turnover is expected to decline to 0.09. In addition to that, Payables Turnover is expected to decline to 0.01. As of April 25, 2024, Common Stock Shares Outstanding is expected to decline to about 777.4 K. In addition to that, Net Loss is expected to decline to about (14.2 M).
Kintara Therapeutics has current Daily Balance Of Power of 0.7.
Most investors in Kintara Therapeutics cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Kintara Therapeutics' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Kintara Therapeutics' price structures and extracts relationships that further increase the generated results' accuracy.
Balance of Power indicator (or BOP) measures the strength of Kintara Therapeutics market sensitivity to bulls and bears. It estimates the ability of Kintara Therapeutics buyers and sellers to push price to an extreme high or extreme low level. As a result, by monitoring Kintara Therapeutics Balance of Power indicator one can determine a trend of the price direction.
Check Kintara Therapeutics VolatilityBacktest Kintara TherapeuticsInformation Ratio  

Kintara Therapeutics Trading Date Momentum

On April 24 2024 Kintara Therapeutics was traded for  0.14  at the closing time. The top price for the day was 0.14  and the lowest listed price was  0.13 . The trading volume for the day was 6 M. The trading history from April 24, 2024 did not cause price change. The trading delta at closing time against the current closing price is 5.11% .
Balance of Power indicator was created by Igor Livshin to predict asset short term price movements or warning signals. If Balance of Power indicator is trended towards the high of its range it will signify that the bulls are in control. On the other hand when the BOP indicator is moving towards the lows of its range it signifies that the bears are in control. If the indicator move from a high positive range to a lower positive range it signifies that the buying pressure is decreasing. Conversely, if the indicator move from a low negative range to a higher negative range it signifies that the selling pressure is decreasing.
Compare Kintara Therapeutics to competition

Other Forecasting Options for Kintara Therapeutics

For every potential investor in Kintara, whether a beginner or expert, Kintara Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Kintara Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Kintara. Basic forecasting techniques help filter out the noise by identifying Kintara Therapeutics' price trends.

View Kintara Therapeutics Related Equities

 Risk & Return  Correlation

Kintara Therapeutics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Kintara Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Kintara Therapeutics' current price.

Kintara Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Kintara Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Kintara Therapeutics shares will generate the highest return on investment. By undertsting and applying Kintara Therapeutics stock market strength indicators, traders can identify Kintara Therapeutics entry and exit signals to maximize returns.

Kintara Therapeutics Risk Indicators

The analysis of Kintara Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Kintara Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting kintara stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Kintara Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Kintara Therapeutics' short interest history, or implied volatility extrapolated from Kintara Therapeutics options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Kintara Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Kintara Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Kintara Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Kintara Therapeutics Stock:
Check out Historical Fundamental Analysis of Kintara Therapeutics to cross-verify your projections.
For information on how to trade Kintara Stock refer to our How to Trade Kintara Stock guide.
You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Complementary Tools for Kintara Stock analysis

When running Kintara Therapeutics' price analysis, check to measure Kintara Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kintara Therapeutics is operating at the current time. Most of Kintara Therapeutics' value examination focuses on studying past and present price action to predict the probability of Kintara Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kintara Therapeutics' price. Additionally, you may evaluate how the addition of Kintara Therapeutics to your portfolios can decrease your overall portfolio volatility.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Is Kintara Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kintara Therapeutics. If investors know Kintara will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kintara Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.22)
Return On Assets
(1.13)
Return On Equity
(3.29)
The market value of Kintara Therapeutics is measured differently than its book value, which is the value of Kintara that is recorded on the company's balance sheet. Investors also form their own opinion of Kintara Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Kintara Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kintara Therapeutics' market value can be influenced by many factors that don't directly affect Kintara Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kintara Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Kintara Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kintara Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.